Atabak Mokari

2020 - BELLICUM PHARMACEUTICALS

In 2020, Atabak Mokari earned a total compensation of $1.7M as Former Chief Financial Officer at BELLICUM PHARMACEUTICALS, a 49% increase compared to previous year.

Compensation breakdown

Option Awards$542,889
Salary$408,373
Stock Awards$163,764
Other$536,708
Total$1,651,734

Mokari received $542.9K in option awards, accounting for 33% of the total pay in 2020.

Mokari also received $408.4K in salary, $163.8K in stock awards and $536.7K in other compensation.

Rankings

In 2020, Atabak Mokari's compensation ranked 6,408th out of 13,090 executives tracked by ExecPay. In other words, Mokari earned more than 51.0% of executives.

ClassificationRankingPercentile
All
6,408
out of 13,090
51st
Division
Manufacturing
2,645
out of 5,618
53rd
Major group
Chemicals And Allied Products
1,067
out of 2,251
53rd
Industry group
Drugs
922
out of 1,951
53rd
Industry
Pharmaceutical Preparations
690
out of 1,456
53rd
Source: SEC filing on April 29, 2021.

Mokari's colleagues

We found two more compensation records of executives who worked with Atabak Mokari at BELLICUM PHARMACEUTICALS in 2020.

2020

Richard Fair

BELLICUM PHARMACEUTICALS

Chief Executive Officer

2020

Shane Ward

BELLICUM PHARMACEUTICALS

Secretary

News

You may also like